Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Liquid biopsies and tumor-informed ctDNA profiling in metastatic urothelial carcinoma

Guru Sonpavde • 18 Feb 2022
GU Cancers 2022
Bladder Cancer Genitourinary Cancer Urothelial Carcinoma

Guru Sonpavde, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of liquid biopsies in the management of metastatic urothelial carcinoma and explains tumor-informed ctDNA profiling. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Guru Sonpavde

1:40
Safety results from Phase 3b STRONG trial of durvalumab in patients with urinary tract carcinoma
Guru Sonpavde • 18 Feb 2022
1:06
Key trials in bladder cancer from ASCO GU 2022
Guru Sonpavde • 18 Feb 2022
1:34
Phase 2 trial of CV301 vaccine plus atezolizumab in advanced urothelial carcinoma
Guru Sonpavde • 18 Feb 2022
0:50
Role of vaccines in urothelial carcinoma
Guru Sonpavde • 18 Feb 2022

Related Videos

10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals